Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies

Chronic lung disease remains the primary cause of mortality in cystic fibrosis (CF). Growing evidence suggests respiratory viral infections are often more severe in CF compared to healthy peers and contributes to pulmonary exacerbations (PEx) and deterioration of lung function. Rhinovirus is the mos...

Full description

Bibliographic Details
Main Authors: Kak-Ming Ling, Luke W. Garratt, Timo Lassmann, Stephen M. Stick, Anthony Kicic, WAERP, AusREC, Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01270/full
id doaj-1f28780486404eeaa2d400272e238b36
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Kak-Ming Ling
Kak-Ming Ling
Luke W. Garratt
Timo Lassmann
Stephen M. Stick
Stephen M. Stick
Stephen M. Stick
Stephen M. Stick
Anthony Kicic
Anthony Kicic
Anthony Kicic
Anthony Kicic
Anthony Kicic
WAERP
AusREC
AusREC
AusREC
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
spellingShingle Kak-Ming Ling
Kak-Ming Ling
Luke W. Garratt
Timo Lassmann
Stephen M. Stick
Stephen M. Stick
Stephen M. Stick
Stephen M. Stick
Anthony Kicic
Anthony Kicic
Anthony Kicic
Anthony Kicic
Anthony Kicic
WAERP
AusREC
AusREC
AusREC
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
Frontiers in Pharmacology
cystic fibrosis
airway epithelium
rhinovirus
innate immune response
therapy
transcriptomic
author_facet Kak-Ming Ling
Kak-Ming Ling
Luke W. Garratt
Timo Lassmann
Stephen M. Stick
Stephen M. Stick
Stephen M. Stick
Stephen M. Stick
Anthony Kicic
Anthony Kicic
Anthony Kicic
Anthony Kicic
Anthony Kicic
WAERP
AusREC
AusREC
AusREC
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
author_sort Kak-Ming Ling
title Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
title_short Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
title_full Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
title_fullStr Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
title_full_unstemmed Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
title_sort elucidating the interaction of cf airway epithelial cells and rhinovirus: using the host-pathogen relationship to identify future therapeutic strategies
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-11-01
description Chronic lung disease remains the primary cause of mortality in cystic fibrosis (CF). Growing evidence suggests respiratory viral infections are often more severe in CF compared to healthy peers and contributes to pulmonary exacerbations (PEx) and deterioration of lung function. Rhinovirus is the most prevalent respiratory virus detected, particularly during exacerbations in children with CF <5 years old. However, even though rhinoviral infections are likely to be one of the factors initiating the onset of CF lung disease, there is no effective targeted treatment. A better understanding of the innate immune responses by CF airway epithelial cells, the primary site of infection for viruses, is needed to identify why viral infections are more severe in CF. The aim of this review is to present the clinical impact of virus infection in both young children and adults with CF, focusing on rhinovirus infection. Previous in vitro and in vivo investigations looking at the mechanisms behind virus infection will also be summarized. The review will finish on the potential of transcriptomics to elucidate the host-pathogen responses by CF airway cells to viral infection and identify novel therapeutic targets.
topic cystic fibrosis
airway epithelium
rhinovirus
innate immune response
therapy
transcriptomic
url https://www.frontiersin.org/article/10.3389/fphar.2018.01270/full
work_keys_str_mv AT kakmingling elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT kakmingling elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT lukewgarratt elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT timolassmann elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT stephenmstick elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT stephenmstick elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT stephenmstick elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT stephenmstick elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT anthonykicic elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT anthonykicic elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT anthonykicic elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT anthonykicic elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT anthonykicic elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT waerp elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT ausrec elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT ausrec elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT ausrec elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT australianrespiratoryearlysurveillanceteamforcysticfibrosis elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT australianrespiratoryearlysurveillanceteamforcysticfibrosis elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT australianrespiratoryearlysurveillanceteamforcysticfibrosis elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
AT australianrespiratoryearlysurveillanceteamforcysticfibrosis elucidatingtheinteractionofcfairwayepithelialcellsandrhinovirususingthehostpathogenrelationshiptoidentifyfuturetherapeuticstrategies
_version_ 1725991633071112192
spelling doaj-1f28780486404eeaa2d400272e238b362020-11-24T21:23:42ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-11-01910.3389/fphar.2018.01270416929Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic StrategiesKak-Ming Ling0Kak-Ming Ling1Luke W. Garratt2Timo Lassmann3Stephen M. Stick4Stephen M. Stick5Stephen M. Stick6Stephen M. Stick7Anthony Kicic8Anthony Kicic9Anthony Kicic10Anthony Kicic11Anthony Kicic12WAERP13AusREC14AusREC15AusREC16Australian Respiratory Early Surveillance Team for Cystic Fibrosis17Australian Respiratory Early Surveillance Team for Cystic Fibrosis18Australian Respiratory Early Surveillance Team for Cystic Fibrosis19Australian Respiratory Early Surveillance Team for Cystic Fibrosis20Paediatrics, Medical School, Faculty of Healthy and Medical Science, University of Western Australia, Nedlands, WA, AustraliaTelethon Kids Institute, University of Western Australia, Nedlands, WA, AustraliaTelethon Kids Institute, University of Western Australia, Nedlands, WA, AustraliaTelethon Kids Institute, University of Western Australia, Nedlands, WA, AustraliaPaediatrics, Medical School, Faculty of Healthy and Medical Science, University of Western Australia, Nedlands, WA, AustraliaTelethon Kids Institute, University of Western Australia, Nedlands, WA, AustraliaDepartment of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA, AustraliaCentre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA, AustraliaPaediatrics, Medical School, Faculty of Healthy and Medical Science, University of Western Australia, Nedlands, WA, AustraliaTelethon Kids Institute, University of Western Australia, Nedlands, WA, AustraliaDepartment of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA, AustraliaCentre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA, AustraliaOccupation and Environment, School of Public Health, Curtin University, Bentley, WA, AustraliaPaediatrics, Medical School, Faculty of Healthy and Medical Science, University of Western Australia, Nedlands, WA, AustraliaPaediatrics, Medical School, Faculty of Healthy and Medical Science, University of Western Australia, Nedlands, WA, AustraliaRobinson Research Institute, University of Adelaide, Adelaide, SA, AustraliaHunter Medical Research Institute: Priority Research Centre for Asthma and Respiratory Disease, New Lambton Heights, NSW, AustraliaPaediatrics, Medical School, Faculty of Healthy and Medical Science, University of Western Australia, Nedlands, WA, AustraliaDepartment of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA, AustraliaMurdoch Children's Research Institute, Melbourne, VIC, AustraliaDepartment of Paediatrics, University of Melbourne, Melbourne, VIC, AustraliaChronic lung disease remains the primary cause of mortality in cystic fibrosis (CF). Growing evidence suggests respiratory viral infections are often more severe in CF compared to healthy peers and contributes to pulmonary exacerbations (PEx) and deterioration of lung function. Rhinovirus is the most prevalent respiratory virus detected, particularly during exacerbations in children with CF <5 years old. However, even though rhinoviral infections are likely to be one of the factors initiating the onset of CF lung disease, there is no effective targeted treatment. A better understanding of the innate immune responses by CF airway epithelial cells, the primary site of infection for viruses, is needed to identify why viral infections are more severe in CF. The aim of this review is to present the clinical impact of virus infection in both young children and adults with CF, focusing on rhinovirus infection. Previous in vitro and in vivo investigations looking at the mechanisms behind virus infection will also be summarized. The review will finish on the potential of transcriptomics to elucidate the host-pathogen responses by CF airway cells to viral infection and identify novel therapeutic targets.https://www.frontiersin.org/article/10.3389/fphar.2018.01270/fullcystic fibrosisairway epitheliumrhinovirusinnate immune responsetherapytranscriptomic